DIVA Laboratories Ltd Cash Flow Reinvestment Rate
DIVA Laboratories Ltd cash flow reinvestment rate. DIVA Laboratories Ltd (4153) has a Cash Flow Reinvestment Rate of 0.04x as of December 2025, reinvesting NT$241.00K (capex NT$241.00K ) from operating cash flow of NT$5.57 Million. Explore 4153 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of DIVA Laboratories Ltd (2017–2025)
Cash flow reinvestment rate of DIVA Laboratories Ltd from 2017 to 2025. Historical reinvestment intensity for DIVA Laboratories Ltd across 7 annual periods. Explore reinvestment intensity of DIVA Laboratories Ltd to see what proportion of operating cash flow is directed to capital expenditures.
DIVA Laboratories Ltd Cash Flow Reinvestment Rate by Year (2017–2025)
DIVA Laboratories Ltd cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for DIVA Laboratories Ltd. For the full cash flow conversion analysis, see DIVA Laboratories Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | NT$1.00 Million | NT$20.77 Million | NT$1.00 Million | ▲ +178.2% |
| 2024 | 0.02x | NT$2.13 Million | NT$123.14 Million | NT$2.13 Million | ▼ -43.1% |
| 2023 | 0.03x | NT$7.69 Million | NT$252.91 Million | NT$7.69 Million | ▼ -86.5% |
| 2022 | 0.22x | NT$16.46 Million | NT$73.19 Million | NT$11.42 Million | ▼ -83.4% |
| 2019 | 1.35x | NT$71.34 Million | NT$52.66 Million | NT$12.79 Million | ▲ +403.6% |
| 2018 | 0.27x | NT$23.14 Million | NT$86.02 Million | NT$21.71 Million | ▼ -81.8% |
| 2017 | 1.48x | NT$61.14 Million | NT$41.45 Million | NT$13.31 Million | — |